These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21692728)

  • 41. Macrofilaricidal activity and amelioration of lymphatic pathology in bancroftian filariasis after 3 weeks of doxycycline followed by single-dose diethylcarbamazine.
    Mand S; Pfarr K; Sahoo PK; Satapathy AK; Specht S; Klarmann U; Debrah AY; Ravindran B; Hoerauf A
    Am J Trop Med Hyg; 2009 Oct; 81(4):702-11. PubMed ID: 19815891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pacific nations lead the way in fighting lymphatic filariasis. Region aims to eliminate.
    Dean M
    Lancet; 2003 Dec; 362(9399):1906. PubMed ID: 14672081
    [No Abstract]   [Full Text] [Related]  

  • 43. [Combinations of ivermectin and diethylcarbamazine for improved control of lymphatic filariasis].
    Moulia-Pelat JP; Nguyen LN; Hascoet H; Nicolas L
    Parasite; 1996 Mar; 3(1):45-8. PubMed ID: 8731761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphatic filariasis: constraints ahead.
    Mishra CP; Singh N
    Indian J Public Health; 2003; 47(1):27-30. PubMed ID: 14723292
    [No Abstract]   [Full Text] [Related]  

  • 45. Mass treatment to eliminate filariasis in Papua New Guinea.
    Bockarie MJ; Tisch DJ; Kastens W; Alexander ND; Dimber Z; Bockarie F; Ibam E; Alpers MP; Kazura JW
    N Engl J Med; 2002 Dec; 347(23):1841-8. PubMed ID: 12466508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elimination of lymphatic filariasis in India.
    Sabesan S; Ravi R; Das PK
    Lancet Infect Dis; 2005 Jan; 5(1):4-5. PubMed ID: 15620551
    [No Abstract]   [Full Text] [Related]  

  • 47. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
    Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
    Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strategic options for global lymphatic filariasis elimination.
    Sabesan S
    Trends Parasitol; 2003 May; 19(5):200-1. PubMed ID: 12763424
    [No Abstract]   [Full Text] [Related]  

  • 49. Elimination of lymphatic filariasis: do we have the drugs to complete the job?
    Bockarie MJ; Deb RM
    Curr Opin Infect Dis; 2010 Dec; 23(6):617-20. PubMed ID: 20847694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lymphatic filariasis.
    Prescrire Int; 2008 Feb; 17(93):36. PubMed ID: 18383658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early-stage elephantiasis in bancroftian filariasis.
    Grobusch MP; Göbels K; Teichmann D; Bergmann F; Suttorp N
    Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):835-6. PubMed ID: 11783706
    [No Abstract]   [Full Text] [Related]  

  • 52. Anti-Wolbachia treatment for lymphatic filariasis.
    Stolk WA; de Vlas SJ; Habbema JD
    Lancet; 2005 Jun 18-24; 365(9477):2067-8. PubMed ID: 15964428
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum immune complexes as diagnostic and therapeutic markers in lymphatic filariasis.
    Dixit V; Gupta AK; Bisen PS; Prasad GB; Harinath BC
    J Clin Lab Anal; 2007; 21(2):114-8. PubMed ID: 17385666
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes.
    Bockarie MJ; Alexander ND; Hyun P; Dimber Z; Bockarie F; Ibam E; Alpers MP; Kazura JW
    Lancet; 1998 Jan; 351(9097):162-8. PubMed ID: 9449870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of ivermectin and diethylcarbamazine on microfilariae and overall microfilaria production in bancroftian filariasis.
    Stolk WA; VAN Oortmarssen GJ; Pani SP; DE Vlas SJ; Subramanian S; DAS PK; Habbema JD
    Am J Trop Med Hyg; 2005 Nov; 73(5):881-7. PubMed ID: 16282298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Albendazole for mass drug administration to eliminate lymphatic filariasis.
    Sabesan S
    Lancet Infect Dis; 2006 Nov; 6(11):684-5. PubMed ID: 17067916
    [No Abstract]   [Full Text] [Related]  

  • 57. [Tropical filarial pulmonary eosinophilia and its differential diagnosis].
    Coutinho AD; Rocha A; Medeiros Z; Dreyer G
    Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(1):42-51. PubMed ID: 9659744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elimination of lymphatic filariasis.
    Michael E; Malecela-Lazaro MN; Kazura JW
    Lancet; 2006 Jul; 368(9533):362-3; author reply 363-4. PubMed ID: 16876654
    [No Abstract]   [Full Text] [Related]  

  • 59. Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India.
    Mukhopadhyay AK; Patnaik SK; Satya Babu P; Rao KN
    J Vector Borne Dis; 2008 Mar; 45(1):73-5. PubMed ID: 18399322
    [No Abstract]   [Full Text] [Related]  

  • 60. Improving community participation to eliminate lymphatic filariasis in American Samoa.
    King JD; Zielinski-Gutierrez E; Pa'au M; Lammie P
    Acta Trop; 2011 Sep; 120 Suppl 1():S48-54. PubMed ID: 20932818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.